The impact of allocation bias on test decisions in clinical trials with multiple endpoints using multiple testing strategies
Abstract Background Considering multiple endpoints in clinical trials provide a more comprehensive understanding of treatment effects and may lead to increased power or reduced sample size, which may be beneficial in rare diseases. Besides the small sample sizes, allocation bias is an issue that aff...
I tiakina i:
| Ngā kaituhi matua: | , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2024-09-01
|
| Rangatū: | BMC Medical Research Methodology |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s12874-024-02335-x |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|